Mirabella Financial Services’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-652
Closed -$215K 461
2024
Q2
$215K Buy
+652
New +$230K 0.02% 388
2023
Q3
Sell
-13,591
Closed -$5.2M 649
2023
Q2
$5.2M Buy
+13,591
New +$4.86M 0.57% 48
2022
Q3
Sell
-1,065
Closed -$319K 573
2022
Q2
$319K Buy
+1,065
New +$347K 0.03% 315
2022
Q1
Sell
-21,864
Closed -$10.3M 698
2021
Q4
$10.3M Buy
21,864
+9,024
+70% +$3.88M 1.04% 16
2021
Q3
$5.45M Sell
12,840
-9,539
-43% -$4.02M 0.72% 40
2021
Q2
$8.04M Sell
22,379
-9,568
-30% -$3.16M 1.44% 12
2021
Q1
$9M Sell
31,947
-10,250
-24% -$2.93M 2.79% 3
2020
Q4
$12M Buy
+42,197
New +$11.8M 1.49% 11

Other funds holding WST

Mirabella Financial Services's WST Position: Q3 2024 in Review

Mirabella Financial Services sold out of West Pharmaceutical (WST) in Q3 2024, closing a stake of 652 shares — an estimated $215K sold.

Mirabella Financial Services first reported a position in WST in Q4 2020 and held it in 8 quarters. The position peaked at $12M in Q4 2020. 730 funds tracked by Wall St. Rank hold WST as of Q3 2024.

  • Mirabella Financial Services reported no remaining West Pharmaceutical position as of Q3 2024 after selling out during the quarter.
  • Mirabella Financial Services sold 652 West Pharmaceutical shares in Q3 2024, an estimated $215K.
  • Mirabella Financial Services first reported a position in West Pharmaceutical in Q4 2020 and held it in 8 quarters.
  • Mirabella Financial Services's West Pharmaceutical position peaked at $12M in Q4 2020.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.

Based on Mirabella Financial Services's 13F filing for Q3 2024, filed 13 Nov 2024.